Morgan Stanley said it is “constructive” on the setup for the fiscal year 2026 but does not see the third quarter as a ‘re-rating catalyst.”
Agilent’s shares have declined 3.25% for the year-to-date period, underperforming the broader market.
Price-sensitive consumers and a lack of big promotional drive dampen outlook for Bath & Body Works’ third quarter, Citi said.
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
BofA reportedly noted that Grab shares have rallied 70% since the beginning of Sept., which fully prices in the firm’s improving fundamentals.
The company started charging $10.26 for .com registrations from September.
Adding to the renewed enthusiasm, Roth MKM analyst Craig Irwin maintained a ‘Buy’ rating with a $20 price target after hosting meetings with Wolfspeed’s management.
Baird upgraded the stock, citing Elastic’s turnaround in execution, disciplined pipeline management, and growing generative AI adoption.
Revenue increased 17% year-over-year (YoY) to €132 million (~$137 million) during the quarter driven by a solid performance in both Tax Free Shopping Solutions and Payments
Agrify’s stock crossed the $53-mark on Friday morning, marking its highest price since July 2023.
